SCHEMBL4777709

SCHEMBL4777709

O=C(NCc1ccc(C(F)(F)F)nc1)c1ccc(NS(=O)(=O)CCc2cc(Cl)cc(Cl)c2)cc1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PPARG P37231 1/20 0.48
PPARA Q07869 1/20 0.48
MEN1 O00255 4/20 0.47
KMT2A Q03164 4/20 0.47
MAPT P10636 3/20 0.47
HTT P42858 1/20 0.47
NPSR1 Q6W5P4 1/20 0.47
SCN3A Q9NY46 3/20 0.45
CA1 P00915 1/20 0.44
CA2 P00918 1/20 0.44
CA7 P43166 1/20 0.44
CA9 Q16790 1/20 0.44
NAMPT P43490 1/20 0.43
DGAT2 Q96PD7 1/20 0.43
ITK Q08881 2/20 0.42
LMNA P02545 1/20 0.42
TDP1 Q9NUW8 2/20 0.41
RORC P51449 1/20 0.41
EPHX2 P34913 3/20 0.40
NR1H4 Q96RI1 3/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4768151 0.85 MAPT (0.49) PPARGPPARAMEN1KMT2AMAPT
SCHEMBL4773151 0.84 MAPT (0.44) MEN1KMT2AMAPTHTTNPSR1
SCHEMBL4767854 0.84 MAPT (0.46) PPARGPPARAMEN1KMT2AMAPT
SCHEMBL5568785 0.83 SCN3A (0.43) PPARGPPARAMEN1KMT2AMAPT
SCHEMBL5567953 0.83 PPARG (0.42) PPARGPPARAMEN1KMT2AMAPT
SCHEMBL4777334 0.83 SCN3A (0.46) PPARGPPARAMEN1KMT2AMAPT
SCHEMBL5571901 0.83 SLC40A1 (0.45) PPARGPPARAMEN1KMT2AMAPT
SCHEMBL5572196 0.83 PPARA (0.42) PPARGPPARAMEN1KMT2AMAPT
SCHEMBL4773250 0.82 SCN3A (0.51) PPARGPPARAMEN1KMT2ASCN3A
SCHEMBL5571585 0.80 MAPK14 (0.44) PPARGPPARAMEN1KMT2AMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070135435-A1 Certain chemical entities, compositions, and methods CYTOKINETICS, INCORPORATED 2007-06-14 US claimed
EP-1942888-A2 CERTAIN CHEMICAL ENTITIES, COMPOSITIONS, AND METHODS Cytokinetics, Inc. (US) 2008-07-16 EP disclosed
US-20070135435-A1 Certain chemical entities, compositions, and methods CYTOKINETICS, INCORPORATED 2007-06-14 US disclosed
WO-2007056078-A2 CERTAIN CHEMICAL ENTITIES, COMPOSITIONS, AND METHODS CYTOKINETICS, INC. (US) 2007-05-18 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070135435-A1 Certain chemical entities, compositions, and methods KIF5B, KIF2C, PLK1 PPARG 2756/4885PPARA 2973/4885MEN1 1302/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.